A/H1N1 flu pandemic: Managing neutropenic sepsis

BMJ (Online)

Volumn 339, Issue 7724, 2009, Pages 768-

  Crawford, S Michael ^a  

^a AIREDALE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; MORTALITY; NEW ZEALAND; PANDEMIC; PRIORITY JOURNAL; UNITED STATES; DIFFERENTIAL DIAGNOSIS; FEVER; INFECTION CONTROL; NEOPLASM; NEUTROPENIA;

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; OSELTAMIVIR;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEOPLASMS; NEUTROPENIA; OSELTAMIVIR;

EID: 70349645807     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3960     Document Type: Letter

References (1)

1. Elliot AJ, Powers C, Thornton A, Obi C, Hill C, Simms I, et al. Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS Direct. BMJ 2009;339:b3403. (27 August.)[Abstract/Free Full Text]